Latest News in WAAW – Page 49
-
NewsPeritoneal dialysis: New treatment option against infections
Researchers have now succeeded in identifying a new drug treatment option for peritonitis following concerns that the bacteria responsible for the life-threatening infections are becoming increasingly resistant to many antibiotics.
-
NewsVaginal suppository with lactobacilli can prevent recurrent cystitis
Scientists find that administration of Lactobacilli could mitigate the differences in vaginal microbiota between women with and without recurrent cystitis.
-
NewsFrequent use of antibiotics linked to severe Covid outcomes
Frequent and diverse use of antibiotics may be associated with developing more severe outcomes after a COVID-19 infection, including death, a new study has shown.
-
NewsNew bacterial blueprint will help fight antibiotic resistance
Scientists have gained high-res structural insights into a key bacterial enzyme, which may help chemists design new drugs to inhibit it and thus suppress disease-causing bacteria.
-
NewsAlarming antibiotic resistance discovered in war-torn Ukraine
Microbiologists investigating bacterial resistance among the war-wounded Ukrainian patients treated in hospitals have warned that the entire European region is under threat after finding that many were affected by bacteria that exhibited an extremely high level of antibiotic resistance.
-
News‘Hospital pathogen’ widespread in Vietnam’s environment
A pathogen considered to be a cause of hospital infection is widespread in Vietnam, turning up in farm soil and pig faeces as well as hospital beds and toilet floor surfaces, with 70% of isolates found to be resistant to at least one class of antimicrobials.
-
NewsAI model can accelerate development of new antivirals
Researchers have shown that IBM’s AI Model, MoLFormer, can generate antiviral molecules for multiple target virus proteins, including SARS-CoV-2, that can accelerate the drug discovery process.
-
NewsMolecular insights may inform new treatments for drug-resistant TB
Researchers have used state-of-the-art imaging to examine two new compounds that target ATP synthase, potentially stopping TB bacteria from producing the energy they need to survive.
-
NewsHeart drug peruvoside could prevent spread of up to 12 viruses
Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families.
-
NewsSingle hepatitis E mutation renders sofosbuvir therapy ineffective
A single mutation of the hepatitis E virus has been shown to cause treatment with the hepatitis C drug sofosbuvir to become much less effective, according to a study that provides new insights for future drug development.
-
NewsDrugs targeting malaria in Mozambique are still effective
The drugs used to treat and prevent malaria in Mozambique are still effective, according to a genomic analysis of drug resistance markers in Plasmodium falciparum, carried out by the Barcelona Institute for Global Health (ISGlobal) and the Manhiça Health Research Center (CISM). Source: CDC/ Dr. Mae Mellvin Photomicrograph ...
-
NewsDrug-resistant fungi thriving in the most remote regions of Earth
New research has found that a disease-causing fungus — collected from one of the most remote regions in the world — is resistant to a common antifungal medicine used to treat infections.
-
NewsBioactive glass doped with silver delivers longer-lasting antimicrobial wound protection
Researchers at the University of Birmingham have demonstrated that silver retains antimicrobial activity for longer when it is impregnated into ‘bioactive glass’, and shown for the first time how this promising combination delivers more long-lasting antimicrobial wound protection than conventional alternatives.
-
NewsBiotech spinoff PHIOGEN to tackle threat of antimicrobial resistance
A new biotech spin-off, PHIOGEN, has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections.
-
NewsTreatment with enzyme inhibitor can help combat antimicrobial resistance
Researchers have shown that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance.
-
![Low-Res_pseudomonas aeruginosa 2[87]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/9/0/4/2904_lowres_pseudomonasaeruginosa287_978595_crop.jpg)
NewsScientists discover small RNA that regulates bacterial infection
Researchers have identified the major mechanism behind the transition between chronic and acute P. aeruginosa infections.
-
NewsNewborns worldwide dying from sepsis as antibiotics lose their bite
A global observational study involving more than 3,200 newborn babies suffering from sepsis in 11 countries has shown that many newborns are dying because the antibiotics used to treat sepsis are losing their effectiveness.
-
![Image[4]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/8/0/9/2809_image4_665121.jpeg)
NewsMicrobiome takes centre stage at keynote lecture
Dr Martin Blaser delivered the Ashford Memorial Lecture 2023, which commemorates the legacy of Dr. Bailey Kelly Ashford, who changed the infectious disease landscape of Puerto Rico in the early 20th century.
-
NewsNovel combination therapy counters antibiotic-resistant Mycobacterium infections
Researchers have discovered a novel therapy by combining two antibiotics, rifaximin and clarithromycin, to treat Mycobacterium abscessus, a non-tuberculous mycobacterium (NTM) that causes chronic lung-related infections.
-
NewsBiological clocks of people and malaria parasites tick in tune
Research could pave the way to new anti-malarials that work by ’jet-lagging’ the parasites that cause the disease.